Advertisement

Topics

Ligand Reports Third Quarter 2017 Financial Results

16:01 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2017, and provided an operating forecast and program updates. “Ligand’s diversifi...

Other Sources for this Article

Ligand Pharmaceuticals Incorporated
Todd Pettingill
Email: investors@ligand.com
Phone: (858) 550-7500
Twitter: @Ligand_LGND
or
LHA Investor Relations
Bruce Voss
Email: bvoss@lhai.com
Phone: (310) 691-7100

NEXT ARTICLE

More From BioPortfolio on "Ligand Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...